img

Global In-vitro Diagnostic Services Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global In-vitro Diagnostic Services Market Insights, Forecast to 2034

In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.

In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations.

Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
Market Analysis and InsightsGlobal In-vitro Diagnostic Services Market
Global In-vitro Diagnostic Services market is expected to reach to US$ 67540 million in 2023, with a positive growth of %, compared with US$ 64460 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, In-vitro Diagnostic Services industry is evaluated to reach US$ 87000 million in 2033. The CAGR will be 4.3% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global In-vitro Diagnostic Services market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global In-vitro Diagnostic Services market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


BioRad
DexCom
Nova Biomedical
OraSure
Pearl Pathways
Phenomenex
Qiagen
Roche Diagnostics
Siemens
Sysmex
Thermofisher
Segment by Type
Infectious Testing
Diabetes Testing
Molecular Testing
Tissue Testing

Segment by Application


Hospitals
Point-Of-Care Testing
Laboratories
Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, In-vitro Diagnostic Services introduction, etc. In-vitro Diagnostic Services Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of In-vitro Diagnostic Services
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-vitro Diagnostic Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Infectious Testing
1.2.3 Diabetes Testing
1.2.4 Molecular Testing
1.2.5 Tissue Testing
1.3 Market by Application
1.3.1 Global In-vitro Diagnostic Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Point-Of-Care Testing
1.3.4 Laboratories
1.3.5 Academic Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-vitro Diagnostic Services Market Perspective (2018-2033)
2.2 Global In-vitro Diagnostic Services Growth Trends by Region
2.2.1 In-vitro Diagnostic Services Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 In-vitro Diagnostic Services Historic Market Size by Region (2018-2023)
2.2.3 In-vitro Diagnostic Services Forecasted Market Size by Region (2024-2033)
2.3 In-vitro Diagnostic Services Market Dynamics
2.3.1 In-vitro Diagnostic Services Industry Trends
2.3.2 In-vitro Diagnostic Services Market Drivers
2.3.3 In-vitro Diagnostic Services Market Challenges
2.3.4 In-vitro Diagnostic Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue In-vitro Diagnostic Services by Players
3.1.1 Global In-vitro Diagnostic Services Revenue by Players (2018-2023)
3.1.2 Global In-vitro Diagnostic Services Revenue Market Share by Players (2018-2023)
3.2 Global In-vitro Diagnostic Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of In-vitro Diagnostic Services, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global In-vitro Diagnostic Services Market Concentration Ratio
3.4.1 Global In-vitro Diagnostic Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostic Services Revenue in 2022
3.5 Global Key Players of In-vitro Diagnostic Services Head office and Area Served
3.6 Global Key Players of In-vitro Diagnostic Services, Product and Application
3.7 Global Key Players of In-vitro Diagnostic Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In-vitro Diagnostic Services Breakdown Data by Type
4.1 Global In-vitro Diagnostic Services Historic Market Size by Type (2018-2023)
4.2 Global In-vitro Diagnostic Services Forecasted Market Size by Type (2024-2033)
5 In-vitro Diagnostic Services Breakdown Data by Application
5.1 Global In-vitro Diagnostic Services Historic Market Size by Application (2018-2023)
5.2 Global In-vitro Diagnostic Services Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America In-vitro Diagnostic Services Market Size (2018-2033)
6.2 North America In-vitro Diagnostic Services Market Size by Type
6.2.1 North America In-vitro Diagnostic Services Market Size by Type (2018-2023)
6.2.2 North America In-vitro Diagnostic Services Market Size by Type (2024-2033)
6.2.3 North America In-vitro Diagnostic Services Market Share by Type (2018-2033)
6.3 North America In-vitro Diagnostic Services Market Size by Application
6.3.1 North America In-vitro Diagnostic Services Market Size by Application (2018-2023)
6.3.2 North America In-vitro Diagnostic Services Market Size by Application (2024-2033)
6.3.3 North America In-vitro Diagnostic Services Market Share by Application (2018-2033)
6.4 North America In-vitro Diagnostic Services Market Size by Country
6.4.1 North America In-vitro Diagnostic Services Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America In-vitro Diagnostic Services Market Size by Country (2018-2023)
6.4.3 North America In-vitro Diagnostic Services Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe In-vitro Diagnostic Services Market Size (2018-2033)
7.2 Europe In-vitro Diagnostic Services Market Size by Type
7.2.1 Europe In-vitro Diagnostic Services Market Size by Type (2018-2023)
7.2.2 Europe In-vitro Diagnostic Services Market Size by Type (2024-2033)
7.2.3 Europe In-vitro Diagnostic Services Market Share by Type (2018-2033)
7.3 Europe In-vitro Diagnostic Services Market Size by Application
7.3.1 Europe In-vitro Diagnostic Services Market Size by Application (2018-2023)
7.3.2 Europe In-vitro Diagnostic Services Market Size by Application (2024-2033)
7.3.3 Europe In-vitro Diagnostic Services Market Share by Application (2018-2033)
7.4 Europe In-vitro Diagnostic Services Market Size by Country
7.4.1 Europe In-vitro Diagnostic Services Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe In-vitro Diagnostic Services Market Size by Country (2018-2023)
7.4.3 Europe In-vitro Diagnostic Services Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China In-vitro Diagnostic Services Market Size (2018-2033)
8.2 China In-vitro Diagnostic Services Market Size by Type
8.2.1 China In-vitro Diagnostic Services Market Size by Type (2018-2023)
8.2.2 China In-vitro Diagnostic Services Market Size by Type (2024-2033)
8.2.3 China In-vitro Diagnostic Services Market Share by Type (2018-2033)
8.3 China In-vitro Diagnostic Services Market Size by Application
8.3.1 China In-vitro Diagnostic Services Market Size by Application (2018-2023)
8.3.2 China In-vitro Diagnostic Services Market Size by Application (2024-2033)
8.3.3 China In-vitro Diagnostic Services Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia In-vitro Diagnostic Services Market Size (2018-2033)
9.2 Asia In-vitro Diagnostic Services Market Size by Type
9.2.1 Asia In-vitro Diagnostic Services Market Size by Type (2018-2023)
9.2.2 Asia In-vitro Diagnostic Services Market Size by Type (2024-2033)
9.2.3 Asia In-vitro Diagnostic Services Market Share by Type (2018-2033)
9.3 Asia In-vitro Diagnostic Services Market Size by Application
9.3.1 Asia In-vitro Diagnostic Services Market Size by Application (2018-2023)
9.3.2 Asia In-vitro Diagnostic Services Market Size by Application (2024-2033)
9.3.3 Asia In-vitro Diagnostic Services Market Share by Application (2018-2033)
9.4 Asia In-vitro Diagnostic Services Market Size by Region
9.4.1 Asia In-vitro Diagnostic Services Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia In-vitro Diagnostic Services Market Size by Region (2018-2023)
9.4.3 Asia In-vitro Diagnostic Services Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Type
10.2.1 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Application
10.3.1 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Country
10.4.1 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 BioRad
11.1.1 BioRad Company Details
11.1.2 BioRad Business Overview
11.1.3 BioRad In-vitro Diagnostic Services Introduction
11.1.4 BioRad Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.1.5 BioRad Recent Developments
11.2 DexCom
11.2.1 DexCom Company Details
11.2.2 DexCom Business Overview
11.2.3 DexCom In-vitro Diagnostic Services Introduction
11.2.4 DexCom Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.2.5 DexCom Recent Developments
11.3 Nova Biomedical
11.3.1 Nova Biomedical Company Details
11.3.2 Nova Biomedical Business Overview
11.3.3 Nova Biomedical In-vitro Diagnostic Services Introduction
11.3.4 Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.3.5 Nova Biomedical Recent Developments
11.4 OraSure
11.4.1 OraSure Company Details
11.4.2 OraSure Business Overview
11.4.3 OraSure In-vitro Diagnostic Services Introduction
11.4.4 OraSure Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.4.5 OraSure Recent Developments
11.5 Pearl Pathways
11.5.1 Pearl Pathways Company Details
11.5.2 Pearl Pathways Business Overview
11.5.3 Pearl Pathways In-vitro Diagnostic Services Introduction
11.5.4 Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.5.5 Pearl Pathways Recent Developments
11.6 Phenomenex
11.6.1 Phenomenex Company Details
11.6.2 Phenomenex Business Overview
11.6.3 Phenomenex In-vitro Diagnostic Services Introduction
11.6.4 Phenomenex Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.6.5 Phenomenex Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen In-vitro Diagnostic Services Introduction
11.7.4 Qiagen Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.7.5 Qiagen Recent Developments
11.8 Roche Diagnostics
11.8.1 Roche Diagnostics Company Details
11.8.2 Roche Diagnostics Business Overview
11.8.3 Roche Diagnostics In-vitro Diagnostic Services Introduction
11.8.4 Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.8.5 Roche Diagnostics Recent Developments
11.9 Siemens
11.9.1 Siemens Company Details
11.9.2 Siemens Business Overview
11.9.3 Siemens In-vitro Diagnostic Services Introduction
11.9.4 Siemens Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.9.5 Siemens Recent Developments
11.10 Sysmex
11.10.1 Sysmex Company Details
11.10.2 Sysmex Business Overview
11.10.3 Sysmex In-vitro Diagnostic Services Introduction
11.10.4 Sysmex Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.10.5 Sysmex Recent Developments
11.11 Thermofisher
11.11.1 Thermofisher Company Details
11.11.2 Thermofisher Business Overview
11.11.3 Thermofisher In-vitro Diagnostic Services Introduction
11.11.4 Thermofisher Revenue in In-vitro Diagnostic Services Business (2018-2023)
11.11.5 Thermofisher Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In-vitro Diagnostic Services Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Infectious Testing
Table 3. Key Players of Diabetes Testing
Table 4. Key Players of Molecular Testing
Table 5. Key Players of Tissue Testing
Table 6. Global In-vitro Diagnostic Services Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global In-vitro Diagnostic Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global In-vitro Diagnostic Services Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global In-vitro Diagnostic Services Market Share by Region (2018-2023)
Table 10. Global In-vitro Diagnostic Services Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global In-vitro Diagnostic Services Market Share by Region (2024-2033)
Table 12. In-vitro Diagnostic Services Market Trends
Table 13. In-vitro Diagnostic Services Market Drivers
Table 14. In-vitro Diagnostic Services Market Challenges
Table 15. In-vitro Diagnostic Services Market Restraints
Table 16. Global In-vitro Diagnostic Services Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global In-vitro Diagnostic Services Revenue Share by Players (2018-2023)
Table 18. Global Top In-vitro Diagnostic Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostic Services as of 2022)
Table 19. Global In-vitro Diagnostic Services Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by In-vitro Diagnostic Services Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of In-vitro Diagnostic Services, Headquarters and Area Served
Table 22. Global Key Players of In-vitro Diagnostic Services, Product and Application
Table 23. Global Key Players of In-vitro Diagnostic Services, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In-vitro Diagnostic Services Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global In-vitro Diagnostic Services Revenue Market Share by Type (2018-2023)
Table 27. Global In-vitro Diagnostic Services Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global In-vitro Diagnostic Services Revenue Market Share by Type (2024-2033)
Table 29. Global In-vitro Diagnostic Services Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global In-vitro Diagnostic Services Revenue Share by Application (2018-2023)
Table 31. Global In-vitro Diagnostic Services Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global In-vitro Diagnostic Services Revenue Share by Application (2024-2033)
Table 33. North America In-vitro Diagnostic Services Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America In-vitro Diagnostic Services Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America In-vitro Diagnostic Services Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America In-vitro Diagnostic Services Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America In-vitro Diagnostic Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America In-vitro Diagnostic Services Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America In-vitro Diagnostic Services Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe In-vitro Diagnostic Services Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe In-vitro Diagnostic Services Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe In-vitro Diagnostic Services Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe In-vitro Diagnostic Services Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe In-vitro Diagnostic Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe In-vitro Diagnostic Services Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe In-vitro Diagnostic Services Market Size by Country (2024-2033) & (US$ Million)
Table 47. China In-vitro Diagnostic Services Market Size by Type (2018-2023) & (US$ Million)
Table 48. China In-vitro Diagnostic Services Market Size by Type (2024-2033) & (US$ Million)
Table 49. China In-vitro Diagnostic Services Market Size by Application (2018-2023) & (US$ Million)
Table 50. China In-vitro Diagnostic Services Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia In-vitro Diagnostic Services Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia In-vitro Diagnostic Services Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia In-vitro Diagnostic Services Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia In-vitro Diagnostic Services Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia In-vitro Diagnostic Services Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia In-vitro Diagnostic Services Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia In-vitro Diagnostic Services Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America In-vitro Diagnostic Services Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size by Country (2024-2033) & (US$ Million)
Table 65. BioRad Company Details
Table 66. BioRad Business Overview
Table 67. BioRad In-vitro Diagnostic Services Product
Table 68. BioRad Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 69. BioRad Recent Developments
Table 70. DexCom Company Details
Table 71. DexCom Business Overview
Table 72. DexCom In-vitro Diagnostic Services Product
Table 73. DexCom Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 74. DexCom Recent Developments
Table 75. Nova Biomedical Company Details
Table 76. Nova Biomedical Business Overview
Table 77. Nova Biomedical In-vitro Diagnostic Services Product
Table 78. Nova Biomedical Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 79. Nova Biomedical Recent Developments
Table 80. OraSure Company Details
Table 81. OraSure Business Overview
Table 82. OraSure In-vitro Diagnostic Services Product
Table 83. OraSure Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 84. OraSure Recent Developments
Table 85. Pearl Pathways Company Details
Table 86. Pearl Pathways Business Overview
Table 87. Pearl Pathways In-vitro Diagnostic Services Product
Table 88. Pearl Pathways Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 89. Pearl Pathways Recent Developments
Table 90. Phenomenex Company Details
Table 91. Phenomenex Business Overview
Table 92. Phenomenex In-vitro Diagnostic Services Product
Table 93. Phenomenex Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 94. Phenomenex Recent Developments
Table 95. Qiagen Company Details
Table 96. Qiagen Business Overview
Table 97. Qiagen In-vitro Diagnostic Services Product
Table 98. Qiagen Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 99. Qiagen Recent Developments
Table 100. Roche Diagnostics Company Details
Table 101. Roche Diagnostics Business Overview
Table 102. Roche Diagnostics In-vitro Diagnostic Services Product
Table 103. Roche Diagnostics Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 104. Roche Diagnostics Recent Developments
Table 105. Siemens Company Details
Table 106. Siemens Business Overview
Table 107. Siemens In-vitro Diagnostic Services Product
Table 108. Siemens Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 109. Siemens Recent Developments
Table 110. Sysmex Company Details
Table 111. Sysmex Business Overview
Table 112. Sysmex In-vitro Diagnostic Services Product
Table 113. Sysmex Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 114. Sysmex Recent Developments
Table 115. Thermofisher Company Details
Table 116. Thermofisher Business Overview
Table 117. Thermofisher In-vitro Diagnostic Services Product
Table 118. Thermofisher Revenue in In-vitro Diagnostic Services Business (2018-2023) & (US$ Million)
Table 119. Thermofisher Recent Developments
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-vitro Diagnostic Services Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global In-vitro Diagnostic Services Market Share by Type: 2022 VS 2033
Figure 3. Infectious Testing Features
Figure 4. Diabetes Testing Features
Figure 5. Molecular Testing Features
Figure 6. Tissue Testing Features
Figure 7. Global In-vitro Diagnostic Services Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global In-vitro Diagnostic Services Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Point-Of-Care Testing Case Studies
Figure 11. Laboratories Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. In-vitro Diagnostic Services Report Years Considered
Figure 14. Global In-vitro Diagnostic Services Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global In-vitro Diagnostic Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global In-vitro Diagnostic Services Market Share by Region: 2022 VS 2033
Figure 17. Global In-vitro Diagnostic Services Market Share by Players in 2022
Figure 18. Global Top In-vitro Diagnostic Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-vitro Diagnostic Services as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by In-vitro Diagnostic Services Revenue in 2022
Figure 20. North America In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America In-vitro Diagnostic Services Market Share by Type (2018-2033)
Figure 22. North America In-vitro Diagnostic Services Market Share by Application (2018-2033)
Figure 23. North America In-vitro Diagnostic Services Market Share by Country (2018-2033)
Figure 24. United States In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe In-vitro Diagnostic Services Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe In-vitro Diagnostic Services Market Share by Type (2018-2033)
Figure 28. Europe In-vitro Diagnostic Services Market Share by Application (2018-2033)
Figure 29. Europe In-vitro Diagnostic Services Market Share by Country (2018-2033)
Figure 30. Germany In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China In-vitro Diagnostic Services Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China In-vitro Diagnostic Services Market Share by Type (2018-2033)
Figure 38. China In-vitro Diagnostic Services Market Share by Application (2018-2033)
Figure 39. Asia In-vitro Diagnostic Services Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia In-vitro Diagnostic Services Market Share by Type (2018-2033)
Figure 41. Asia In-vitro Diagnostic Services Market Share by Application (2018-2033)
Figure 42. Asia In-vitro Diagnostic Services Market Share by Region (2018-2033)
Figure 43. Japan In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America In-vitro Diagnostic Services Market Share by Country (2018-2033)
Figure 53. Brazil In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries In-vitro Diagnostic Services Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. BioRad Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 60. DexCom Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 61. Nova Biomedical Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 62. OraSure Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 63. Pearl Pathways Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 64. Phenomenex Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 65. Qiagen Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 66. Roche Diagnostics Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 67. Siemens Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 68. Sysmex Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 69. Thermofisher Revenue Growth Rate in In-vitro Diagnostic Services Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed